HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A X Zhu Selected Research
A X Zhu Research Topics
Disease
5
Neoplasms (Cancer)
01/2019 - 07/2007
3
Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 07/2007
2
Hypertension (High Blood Pressure)
12/2017 - 04/2013
2
Adenocarcinoma
07/2014 - 06/2011
2
Neutropenia
04/2013 - 03/2009
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1
Hemorrhage
12/2017
1
Proteinuria
12/2017
1
Ischemia
09/2014
1
Reperfusion Injury
09/2014
1
Hypoxia (Hypoxemia)
09/2014
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2014
1
Gallbladder Neoplasms (Gallbladder Cancer)
07/2014
1
Rectal Neoplasms (Rectal Cancer)
01/2014
1
Pathologic Complete Response
01/2014
1
Stroke (Strokes)
04/2013
1
Lymphopenia (Lymphocytopenia)
04/2013
1
Pulmonary Embolism
04/2013
1
Thrombocytopenia (Thrombopenia)
04/2013
1
Carcinoma (Carcinomatosis)
06/2011
1
Hepatitis
09/2010
1
Infections
09/2010
1
Fibrosis (Cirrhosis)
09/2010
1
Nausea
03/2009
1
Anorexia
03/2009
1
Thrombosis (Thrombus)
03/2009
1
Fatigue
03/2009
1
Embolism (Embolus)
03/2009
1
Diarrhea
03/2009
Drug/Important Bio-Agent (IBA)
3
Fluorouracil (Carac)
FDA Link
Generic
01/2014 - 07/2007
2
Monoclonal Antibodies
IBA
12/2017 - 06/2011
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
07/2014 - 07/2007
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2014 - 07/2007
2
Bevacizumab (Avastin)
FDA Link
01/2014 - 07/2007
2
ErbB Receptors (EGF Receptor)
IBA
06/2011 - 07/2007
1
Catenins
IBA
01/2019
1
Peptides (Polypeptides)
IBA
01/2019
1
Hydrocarbons
IBA
01/2019
1
Immune Checkpoint Inhibitors
IBA
01/2019
1
Ramucirumab
IBA
12/2017
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
12/2017
1
Angiogenesis Inhibitors
IBA
12/2017
1
Immunoglobulins (Immunoglobulin)
IBA
12/2017
1
salicylhydroxamic acid (SHAM)
IBA
09/2014
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2014
1
Platinum
IBA
07/2014
1
Gemcitabine
FDA Link
07/2014
1
Panitumumab (Vectibix)
FDA Link
07/2014
1
Uric Acid (Urate)
IBA
04/2013
1
Cetuximab (Erbitux)
FDA Link
06/2011
1
Tyrosine Kinase Inhibitors
IBA
06/2011
1
Aflatoxins
IBA
09/2010
1
Cisplatin (Platino)
FDA Link
Generic
03/2009
1
Docetaxel (Taxotere)
FDA Link
03/2009
1
Irinotecan (Camptosar)
FDA Link
Generic
03/2009
1
Leucovorin (Folinic Acid)
FDA Link
07/2007
1
MAC321
IBA
07/2007
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2007
Therapy/Procedure
6
Therapeutics
01/2019 - 07/2007
1
Ischemic Postconditioning
09/2014
1
Radiotherapy
01/2014